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The use of food additives with xanthine oxidase (XO) inhibitory activity of-
fers an alternative approach to hyperuricemic and gout disease treatment, and 
provides an example of antioxidant nutraceutics. The in vitro and in silico 
XO inhibitory activity of polyphenols from Uruguayan Tannat grape pomac-
es and propolis extracts was evaluated as well as the scavenging capacity of 
said compounds. When comparing propolis and grape pomace samples, the 
in vitro studies demonstrated that polyphenols extracted from propolis are 
more active as free radical scavengers than those from Tannat grape pomace. 
Both natural products effectively inhibited XO but the capacity of phenols 
present in GP is higher than the one present in P. The high content of antho-
cyanins in GP, absent in P, could account for this observation. In silico assays 
allowed us to determine relevant ligand-receptor interactions between poly-
phenols, from a database built with previously reported polyphenols from 
both natural products, and the active site of XO. The in silico results showed 
that compound (E)-isoprenylcaffeate from propolis was the best potential XO 
inhibitor displaying hydrophobic aromatic interaction between the conju-
gated ring of the caffeate moiety and polar interactions between hydroxyl 
groups from caffeate with the active site polar residues. Among grape po-
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maces, the Cyanidin-3-O-(6-(E)-p-coumaroyl)-glucoside was the best XO in-
hibitor; its moiety oxychromenyl being relevant to the docking stabilization. 
All these results lead us to propose Uruguayan propolis and Tannat grape 
pomace extracts as food additives as well as phytopharmaceuticals to decrease 
the uric acid levels in gout disease and to act against oxidative stress. 
 
Keywords 




Xanthine oxidase (XO) participates in purine catabolism, generating uric acid as 
a final product and the release of reactive oxygen species (ROS) such as 2O
−  
and H2O2. The exacerbated synthesis of uric acid causes the development of gout 
disease [1] [2]. At the same time, ROS are responsible for triggering a lot of dis-
orders such as atherosclerosis, ageing, cancer, ulcer and inflammation [3] [4] [5] 
[6] [7]. Current gout treatments are palliative at the level of pain and chronic in-
flammation, and although treatments involving xanthine oxidase inhibitors are 
available, serious adverse effects have been reported [8]. In this context, natural 
products represent an important alternative. In particular, numerous polyphe-
nols have been reported as relevant XO inhibitors [1] [2] [9] [10] [11] [12]. In 
addition, recent in vitro and in silico reports on XO inhibition by quercetin (a 
natural flavonoid) gave consistent and promising information to consider this 
natural flavonoid as a relevant compound for preventing gout and oxidative 
damage [13]. The antioxidant action mechanism of quercetin and its role on the 
inhibition of XO catalysis was also proposed. In this sense, the binding site for 
quercetin was mapped near the molybdopterin cofactor where the oxidation of 
xanthine (natural substrate) takes place. Thereafter, the reduction of the sub-
strate oxygen is mediated by the isoalloxazine ring of the flavin adenine dinuc-
leotide (FAD) center, transferring electrons and generating ROS like superoxide 
radical anion ( 2O
− ) or hydrogen peroxide (H2O2) [13] [14]. 
Propolis (P) is a natural resinous product elaborated by honeybees (Apis mel-
lifera) that displays a lot of biological activities such as antibacterial, antiviral, 
antifungal, anti-inflammatory, anticancer, and antioxidant [15] [16]. 
Grape pomaces (GP) are a by-product of wine industry and consist mainly of 
peels (skins), seeds and stems. Antioxidant, antimicrobial, antimutagenic, anti-
carcinogenic and antilipogenic activities have been reported for GP [17] [18]. 
Both P and GP, have been described as important sources of bioactive com-
pounds, most of them polyphenols [17] [19] [20] [21] [22]. In this context, Yo-
shizumi et al. [16] suggested that a continuous intake of Chinese propolis may 
be effective for the prevention and the treatment of gout and hyperuricemia. 
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Furthermore, ethanolic extracts from grape pomace increase the antioxidant 
properties of wines [18]. 
In this work, we studied the total phenolic contents, the scavenging activity 
and, for the first time, the in vitro XO inhibitory activity of polyphenolic rich 
extracts from Uruguayan propolis and Tannat grape pomace. In addition, in si-
lico assays were performed in an attempt to account for the molecular basis of 
the interaction between the enzyme and polyphenols-like compounds, present in 
the extracts according to previous reports [23] [24]. 
2. Materials and Methods 
2.1. General 
Folin-Ciocalteu’ phenol reagent, 1,1-diphenyl-2-picryl-hydrazyl (DPPH•), gallic 
acid, ascorbic acid and sodium carbonate (Na2CO3) were obtained from Sigma 
(Sigma-Aldrich® GmbH, Sternheim, Germany). Methanol was obtained from 
Merck®. All other chemicals used were of analytical grade. For the XO inhibition, 
a Sigma-Aldrich Xanthine Oxidase Activity Assay Kit was used (cat. MAK078, 
Sigma-Aldrich®, St. Louis, MO). Measures were obtained from Elisa Thermo® 
Scientific Labsystems MultiskanTM RC. 
2.2. Samples and Extracts 
P and GP sampling and the respective extraction procedures were developed by 
our group and previously published [23] [24]. Briefly, propolis and Tannat grape 
pomace samples were collected in different zones form the south region of Uru-
guay. 
2.2.1. Propolis Extracts 
Samples of 1g weight were separately extracted. Waxes were removed by Soxhlet 
in 200 mL hexane during one hour and 12 refluxes. After evaporating the hexane 
and drying, they were grinded and phenols were extracted with ethanol-water 
(80 - 20 v/v) during one hour at a 75˚C. Finally, 25 mL of extract were filtered 
and diluted to 50 mL with the same extraction solvent. The liquid extracts were 
stocked in dark at 4˚C until their analysis. 
2.2.2. Grape Pomace Extracts 
Frozen grape pomace samples were submitted during 24 hours to drying in va-
cuum at a temperature of 60˚C. The dry grape pomace samples were grinded 
and stocked in darkness. Phenols were extracted by reflux in a mixture of etha-
nol-water (80 - 20 v/v) during 2 hours at 50˚C. After filtering, the extracts were 
conserved at 4˚C in darkness until their use. 
2.3. Total Phenolic Content (Folin-Ciocalteau) 
Total phenolic content was determined by means of Folin-Ciocalteau reagent 
using the method described by Singleton et al. [25]. The results are reported as 
mean values of GAE (gallic acid equivalents) in μM, using the calibration curve 
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prepared with gallic acid standard solutions. 
2.4. DPPH Radical Scavenging Activity 
Free radical scavenging activities of extracts were analyzed, based on the prin-
ciple of scavenging the DPPH (1,1-diphenyl-2-picrylhydrazyl) radical. The ab-
sorbance was measured at 517 nm; the procedure was the same described in 
Shimada et al. [26]. Acid ascorbic was used as a positive control and the results 
are reported as mean values of grams of ascorbic acid equivalents per 100 g dry 
extract. 
2.5. In Vitro XO Inhibition Assays 
The Xanthine Oxidase activity assay kit was used according to the manufacturer 
instructions. The measure of XO activity was performed by an enzyme assay, 
leading to a colorimetric (570 nm) blue product, proportional to the generated 
hydrogen peroxide (cat. MAK078, Sigma-Aldrich®, St. Louis, MO). Assays were 
performed in 15 min according to supplier instruction using 5 µL of samples in 
triplicate. 
2.6. Xanthine Oxidase in Silico Assays 
2.6.1. In Silico General Tools and Modeling 
All in silico calculations and procedures were performed with the Molecular 
Operating Environment MOETM, 2015.10 [27]. To build the database, 123 phe-
nolic structures from bibliographic sources [20] [24] [28] [29] [30] [31] were 
modeled and refined by energy minimization, using the MMF94x force field 
[32]. The resulting phenolic database was previously reported [24]. 
The X-ray structure of mammalian xanthine oxidase complexed with querce-
tin (flavonoid inhibitor) at 2.0 Å resolution was obtained from the RCSB Protein 
Data Bank (PDBid: 3NVY) [14]. 
2.6.2. Xanthine Oxidase Docking Procedure 
The aforementioned crystallographic structure of the XO-quercetin complex was 
used as starting point for the docking procedure. As expected, one of the de-
tected sites was the active site which accommodates quercetin, the same site 
identified by Hille et al. [33] next to the molybdopterin cofactor. The benzopy-
ran moiety of quercetin is oriented between Phe914 and Phe1009 residues and 
the B ring is next to the molybdopterin cofactor named MTE1327-MOS1228, at 
the active site [14] [33]. 
For the docking calculations, a 4.5 Å sphere centered on quercetin was consi-
dered. The docked quercetin pose overlapped nicely the ligand crystallographic 
pose, with a 2.8 Å root mean square deviation (RMSD) when Alpha Triangle 
(placement), Affinity ΔG (scoring) and final force field (MMFF94x) refinement 
were used. The docking scores were calculated with the Affinity ΔG function. 
This scheme had been developed previously by us [12] [23] [24]. The highest 
ranked poses were evaluated using the score and the relative position with re-
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spect to the native ligand [14]. The graphical representations of the calculated 
binding poses were performed by Surface Maps, and Ligand Interaction MOETM 
tools [34]. 
3. Results and Discussion 
The results for the different samples of Uruguayan propolis and tannat gape 
pomaces are summarized in Table 1. All samples were collected from the south 
of Uruguay near Montevideo and then analyzed, to determine the amount of 
phenolic compounds. Phenolic contents were obtained by Folin-Ciocalteu and 
they are expressed as GAE (gallic acid equivalents) in μM. DPPH. Radical sca-
venging activities are expressed as AEAC (ascorbic acid equivalent antioxidant 
capacity) in μM. Table 1 also presents the in vitro XO inhibitory activity (%) of 
all samples. 
3.1. Total Phenolic Content (Folin-Ciocalteau) 
Both types (e.g. propolis and grape pomaces) of hydroalcoholic extracts showed 
different amount of polyphenols with the same extraction mixture. Phenolic 
contents of propolis extracts are higher (mean = 10.9 ± 0.3 GAE μM), than those 
of grape pomace (mean = 5.5 ± 0.9 GAE μM), evidencing that propolis extracts 
present more polyphenolic content (Table 1). The GP 2010 Tannat sample (ex-
tracted in 2013) presented fewer phenols than the Tannat sample extracted in 
the same year that was collected (GP 2013), suggesting that the amount of poly-
phenols from grape pomace samples probably decreases with aging. 
3.2. DPPH Radical Scavenging Activity and Xantine Oxidase in  
Vitro Assays 
The evaluation of the antioxidant potential from the extracts was performed by 
the DPPH radical scavenging method. The results depicted in Table 1 show that 
the extracted polyphenols from propolis are far more active as free radical sca-
vengers than those from grape pomace extracts. However, XO inhibition of P 
extracts is only slightly higher than that of GP ones (mean values of 44% and 
36%, respectively). Considering that the total amount of phenols in GP is half 
the one measured in P, it may be suggested that the specific potency of phenols 
present in GP is higher than the capacity of those phenols present in P. In par-
ticular, the high content of anthocyanins in GP could account for this observa-
tion. 
This hypothesis is further substantiated by previous studies that found that 
anthocyanins were effective XO inhibitors [18] [35] [36] [37]. At the same time, 
other works reported that anthocyanins are present in GP extracts [17] [19] [23] 
[24]. But absent in P extracts [23] [24] [38]. 
Previously, it was also reported that, while the concentration of polyphenols 
remains constant after wine maturation, the anthocyanins concentration is di-
minished [39]. These finding may be also correlated with our observations in GP  
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Table 1. Phenolic content (μM GAE), radical scavenger activity (μM DPPH) and XO in 
vitro inhibitory activity (%) of different samples (obtained in the years indicated) of 
Uruguayan propolis (P) and Tannat grape pomaces (GP). 
Sample code 
GAEa 
μM + SD 
DPPHb 
μM + SD 
XO inhibition activity 
(%) + SD 
P1 2008 10.4 + 0.2 --- 68.8 + 0.9 
P2 2008 12.3 + 0.1 37.0 + 0.0 41.7 + 0.0 
P3 2008 14.3 + 0.1 37.3 + 0.2 68.1 + 0.6 
P4 2009 11.0 + 0.1 36.9 + 0.5 39.6 + 0.9 
P5 2009 13.2 +0.1 37.8 + 0.1 20.8 + 0.4 
GP 2010 Tannat  
(extracted in 2013) 
3.3 + 0.5 1.9 + 1.4 15.3 + 0.5 
GP 2013 Tannat 7.7 + 1.2 10.3 + 1.4 56.3 + 0.9 
P6 2013 4.0 + 0.2 16.2 + 1.0 25.0 + 0.4 
aGallic acid equivalents, bAscorbic acid equivalent antioxidant capacity (AEAC). Propolis samples were la-
beled with a consecutive number and with their collected and extracted year. Year of collection and extrac-
tion was the same for all samples except for sample GP 2010 which was collected in 2010 but extracted in 
2013. All samples were collected from the South of Uruguay. 
 
extracts: the decrease in XO inhibitory activity through time could be due to the 
decrease in anthocyanins concentration. However, more thorough studies are 
necessary to prove this hypothesis correct. 
The in vitro results suggest that the extracted compounds are responsible for 
the XO inhibitory activity and, in turn, would be able to cause the decline in the 
amount of free radicals and the uric acid deposits. Indeed, the events mediated 
by polyphenols might cause a decrease in the evolution of gout disease, as well as 
the tissue damage reduction usually observed in other pathologies associated 
with an increase in ROS generation such as ischemia-reperfusion among others 
[40]. 
3.3. Xanthine Oxidase in Silico Data Analysis 
Table S1 (Supplementary Material) lists the 60 best docked scores from the 123 
phenolic compounds database previously found in propolis [15] [28] [29] and 
grapes [20]. This very same database was previously reported by us [24]. 52 of 
the 60 compounds belong to GP extracts. This is consistent with the in vitro re-
sults observed for GP and P extracts from the same year, which show that the 
former presented the best inhibition. 
3.4. Docking Calculations 
The best docked compound, the hydroxycinnamic acid derivative, ester (E)- 
isoprenylcaffeate (score = −5.7884 kcal∙mol−1) belonged to propolis extracts. 
When a ligand interaction plot was performed for this compound, an interesting 
π-π stacking interaction was observed between the caffeate moiety and Phe914 at 
a distance of 3.75 Å and next to cofactor molybdopterin (molybdenum center), 
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see Figure 1. This interaction stabilizes the structure; a similar stacking was de-
scribed by Wróblewski et al. [41] and by Cao et al. [14]. The isoprenyl portion 
appears exposed to the solvent (Figure 1). 
In the Tannat GP extracts, the best docked compound was the anthocyanin 
named cyanidin-3-O-(6-(E)-p-coumaroyl)-glucoside. In Figure 2, the most im-
portant interactions with the XO active site are depicted. The same π-π stacking 
interaction found for the binding of ester (E)-isoprenylcaffeate was also verified 
here but now between the coumaroyl moiety and Phe914 at a distance of 3.70 Å 
(also next to cofactor molybdopterin (molybdenum center). A hydrogen bond-
ing with Thr1010 and an ionic interaction with Glu879 were also observed. 
The results for both compounds in Figure 1 and Figure 2 suggest that the ac-
ceptor hydrogen bond interactions with the active site residue side chains, plus 
the hydrophobic factor embodied by π-π interactions between Phe914 and phe-
nolic rings, play an important role in XO inhibition mechanism, as was pre-
viously suggested by Cao et al. [14]. Also, a hydrophilic environment seems to be 
preferred for the inhibitors, next to the molybdenum center near Arg880, Ser876, 
Glu802 or Glu1261. 
The comparison between the in silico results and the in vitro experiments for 
XO inhibition would endorse our previous hypothesis in relation to the impor-
tance of anthocyanins. In effect, even allowing for the fact that the score differ-
ences are rather small across all compounds in Table S1, anthocyanins represent 
over 60% of the 60 best docked compounds in XO, and half of the 10 best com-
pounds. 
4. Conclusions 
XO inhibition and scavenging of free radicals are potentially a powerful strategy 
for hyperuricemia and the fight against oxidative stress. 
In this work, we were able to prove that the Uruguayan P and Tannat GP ex-
tracts can act as free radical scavengers, with samples of propolis being signifi-
cantly more active than those of grape pomaces. In addition, we have shown that 
P and GP samples are capable, to different extents, of inhibiting XO. However, 
XO inhibition by P extracts is only slightly higher than GP. Considering that the 
total amount of phenols in GP is half of that measured in P, we attribute these 
results to the anthocyanin-like compounds, only present in GP extracts. In other 
words, we believe that the superior inhibitor ability of GP extracts is mainly due 
to the high concentration of anthocyanins present in the early stages of the grape 
pomaces. Further experimental assays that measure the exact concentration of 
anthocyanins are necessary to confirm this hypothesis. 
The molecular docking results were used to determine the way in which the 
phenolic compounds would interact with XO’s active site. In effect, considering 
the results yielded by the best docked compounds, it can be concluded that, at 
the molecular level, three different types of interactions are established with the 
enzyme: a) hydrophobic aromatic interactions between the conjugated ring of  
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Figure 1. 2D Electrostatic Surface Map and Ligand Interaction of the best docked ligand from all samples, ester (E)-isoprenyl- 
caffeate (score = −5.7884 kcal∙mol−1) displayed in yellow. 
 
 
Figure 2. 2D Electrostatic Surface Map and Ligand Interaction of the best docked compound from GP extracts, Cyani-
din-3-O-(6-(E)-p-coumaroyl)-glucoside, displayed in violet. 
 
the caffeate moiety and the conjugated coumaroyl ring, with the active site phe-
nylalanine residues; b) polar interactions between hydroxyl groups of caffeate 
and active site polar residues; c) the moiety oxychromenylium from anthocya-
nins which is relevant to the docking stabilization, and gives to this kind of 
compounds enough interaction capacity expressed in their higher scores. Also, 
important interactions with residues that are relevant to the catalytic function of 
the XO were observed. 
The combination of in vitro and in silico techniques and procedures applied 
here to study the nature of enzyme inhibition mechanisms and biological activi-
ties helped us to comprehend the antioxidant functionality that a mixture of ex-
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tracts obtained from two natural products may have. We believe that the synergy 
between both kinds of methodologies is fundamental for the discovering of new 
drugs, and in this case, of potential additives for functional foods. In effect, grape 
pomace could constitute a cheap source of dietary antioxidants because they are 
secondary products of wine manufacturing. In the case of propolis, this product 
is consumed in small quantities by the population, so these results could consti-
tute a good opportunity to add value to it. 
In summary, according to our results we postulate that, either by inhibiting 
XO or by the scavenging of free radicals, propolis and grape pomace extracts 
may reduce the amount of free radicals and uric acid deposits. Thus, these natu-
ral products may be considered as functional foods and good candidates to de-
velop phytopharmaceuticals for gout disease treatment.  
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Supplementary Information (SI) 
Table S1. Xanthine oxidase docking scores (Affinity ΔG algorithm), of the 60 best docked compounds. A PubChem code as a 
compound identifier (CID) is given in parentheses, (*CID refers to a CID parent code). Origin of compounds denoted as “P” 
(Propolis) or “GP” (grapes). Basic structural scaffolds as follows: PHE AC: Phenolic acids; PROCY: Procyanidins; ANTHO: An-
thocyanins; FLAV: Flavonoid; STYL: Stylbene; CAT: Catechin. 
Name** XO Scores (kcal∙mol−1) Origin** Structure** 
(E)-isoprenylcaffeate (5281790) −5.7884 P PHE AC Ester 
Cyanidin-3-O-(6-(E)-p-coumaroyl)-glucoside (5282067) −5.6533 GP ANTHO 
Pyruvic derivative of malvidin-3-O-glucoside (443652) −5.3929 GP ANTHO 
Pyruvic derivative of delphinidin-3-O-(6-p-coumaroyl)-glucoside (15922818) −5.3318 GP ANTHO 
(Z)-isoprenylcaffeate (5281790) −5.3258 P PHE AC Ester 
Malvidin-3-O-(6-(E)-p-coumaroyl)-glucoside-4-vinylcatechol (*44256995) −5.3088 GP ANTHO 
Petunidin-3-O-glucoside-4-vinylcatechol (*443651) −5.1905 GP ANTHO 
(E)-phenethylcaffeate (CAPE) (5881787) −5.1849 P PHE AC Ester 
5-methoxypinobanksin-3-O-pentanoate (147459) −5.1234 GP FLAV Ester 
(E)-cinnamylcaffeate (5281787) −5.0530 P PHE AC Ester 
Pinobanksin-3-O-acetate (148556) −5.0341 P FLAV Ester 
Malvidin-3-O-(6-acetyl)-glucoside-4-vinylguaiacol (*44257037) −4.9974 GP ANTHO 
Peonidin-3-O-glucoside-4-vinylguaiacol (*443654) −4.9925 GP ANTHO 
Petunidin-3-O-(6-(Z)-p-coumaroyl)-glucoside (44256963) −4.9893 GP ANTHO 
Malvidin-3-O-glucoside-4-vinylguaiacol (44257037) −4.9663 GP ANTHO 
(E)-caftaric acid (6440397) −4.9550 GP PHE AC 
Delphinidin-3-O-(6-(E)-p-coumaroyl)-glucoside (15922818) −4.9364 GP ANTHO 
Procyanidin B2 3’-gallate (*122738) −4.9230 GP PROCY 
(E)-resveratrol (445154) −4.7791 P/GP STYL 
Malvidin-3-O-(6-acetyl)-glucoside-4-vinylphenol (*44257035) −4.7603 GP ANTHO 
(E)-isoprenyl-p-coumarate (*637542) −4.7592 P PHE AC Ester 
Delphinidin-3-O-(6-(Z)-p-coumaroyl)-glucoside (44256898) −4.7251 GP ANTHO 
Malvidin-3-O-glucoside-4-vinylcatechol (44257036) −4.7080 GP ANTHO 
Petunidin-3-O-glucoside-4-vinylphenol (*443651) −4.6519 GP ANTHO 
Peonidin-3-O-(6-(E)-p-coumaroyl)-glucoside (443654) −4.6496 GP ANTHO 
Vitisin B of malvidin-3-O-(6-p-coumaroyl)-glucoside (71308302) −4.6318 GP ANTHO 
Malvidin-3-O-(6-(E)-p-coumaroyl)-glucoside-4-vinylphenol (*44256995) −4.5634 GP ANTHO 
Quercetin-7-O-neohesperidoside (*5280343) −4.5625 GP FLAV Glyc 
Peonidin-3-O-glucoside-4-vinylphenol (*443654) −4.5593 GP ANTHO 
(E)-bencylcaffeate (5919576) −4.5426 P PHE AC 
Petunidin-3-O-(6-(E)-p-coumaroyl)-glucoside (176449) −4.5289 GP ANTHO 
Cyanidin-3-O-(6-(Z)-p-coumaroyl)-glucoside (5282067) −4.4787 GP ANTHO 
(Z)-isoprenyl-p-coumarate (*637542) −4.4233 GP PHE AC Ester 
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Continued 
Pyruvic derivative of delphinidin-3-O-glucoside (165558) −4.3155 GP ANTHO 
Pyruvic derivative of peonidin-3-O-(6-acetyl)-glucoside −4.3068 GP ANTHO 
Pyruvic derivative of petunidin-3-O-(6-p-coumaroyl)-glucoside (72193651) −4.2970 GP ANTHO 
(Z)-caftaric acid (72551521) −4.2795 GP PHE AC 
Delphinidin-3-O-(6-acetyl)-glucoside (15385440) −4.2767 GP ANTHO 
Quercetin-3-O-galactoside (5281643) −4.2540 GP FLAV Glyc 
Pyruvic derivative of peonidin-3-O-glucoside (443654) −4.2522 GP ANTHO 
3.4-dihydroxyvinylbencene (151398) −4.2318 P STYL 
Malvidin-3-O-glucoside-4-vinylphenol (44257035) −4.2188 GP ANTHO 
(E)-caffeic acid (717531) −4.2118 P PHE AC 
Pyruvic derivative of malvidin-3-O-(6-p-coumaroyl)-glucoside (72193651) −4.2087 GP ANTHO 
Vitisin B of malvidin-3-O-(6-acetyl)-glucoside (*71308302) −4.2065 GP ANTHO 
Apigenin (5280443) −4.1989 P FLAV 
Methylgallate (7428) −4.1983 GP FLAV 
Procyanidin B3 (4R-8 (+)C(-)C) (146798) −4.1970 GP PROCY 
Delphinidin-3-O-glucoside-4-vinylphenol (*443650) −4.1664 GP ANTHO 
Pyruvic derivative of delphinidin-3-O-(6-acetyl)-glucoside (15385440) −4.1439 GP ANTHO 
(+)-gallocatechin (65084) −4.1433 GP CAT 
Isorhamnetin-3-O-glucoside (5318645) −4.1284 GP FLAV Glyc 
Procyanidin B8 (4R-6 (+)C(+)E) (130556) −4.1111 GP PROCY 
Fisetin (5281614) −4.1051 P FLAV 
Malvidin-3-O-(6-acetyl)-glucoside-4-vinylcatechol (*44257036) −4.0565 GP ANTHO 
Peonidin-3-O-glucoside (443654) −4.0496 GP ANTHO 
Oroxylin A (5320315) −4.0489 GP ANTHO 
Petunidin-3-O-(6-acetyl)-glucoside (44256961) −4.0434 GP ANTHO 
Naringin (442428) −4.0359 P FLAV 
Malvidin-3-O-(6-(E)-caffeoyl)-glucoside (44256989) −4.0332 GP ANTHO 
**Names, origin and structures were taken from Paulino et al. [24] with permission of all co-authors. 
 
 
 
